CVE Vulnerability

CVE-2018-5237

Symantec Endpoint Protection prior to 14 RU1 MP1 or 12.1 RU6 MP10 could be susceptible to a privilege escalation vulnerability, which is a type of issue that allows a user to gain elevated access to resources that are normally protected at lower access levels.

6.5 /10

CVSS v2.0 :

V3 Legend

Vector :

Exploitability : 8 / Impact : 6.4

Attack Vector

Attack Complexity

Privileges Required

User Interaction

Confidentiality Impact PARTIAL

Integrity Impact PARTIAL

Availability Impact PARTIAL

Scope

8.8 /10

CVSS v3.0 : HIGH

V3 Legend

Vector :

Exploitability : 2.8 / Impact : 5.9

Attack Vector NETWORK

Attack Complexity LOW

Privileges Required LOW

User Interaction NONE

Confidentiality Impact HIGH

Integrity Impact HIGH

Availability Impact HIGH

Scope UNCHANGED

References
Link Resource
https://support.symantec.com/en_US/article.SYMSA1454.html Vendor Advisory
http://www.securityfocus.com/bid/104199 Third Party Advisory VDB Entry
http://www.securitytracker.com/id/1041180 Third Party Advisory VDB Entry
Configurations

Configuration 1

cpe:2.3:a:symantec:endpoint_protection:*:*:*:*:*:*:*:*
cpe:2.3:a:symantec:endpoint_protection:12.1:ru6mp10:*:*:*:*:*:*
cpe:2.3:a:symantec:endpoint_protection:14.0:ru1mp1:*:*:*:*:*:*
Information

Published : 2018-06-20 04:29

Updated : 2019-10-03 12:03

NVD link : CVE-2018-5237

Mitre link : CVE-2018-5237

Products Affected
No products.
CWE
NVD-CWE-noinfo